Código QR

Bacterial DnaK reduces the activity of anti-cancer drugs cisplatin and 5FU

Abstract Background Chemotherapy is a primary treatment for cancer, but its efficacy is often limited by cancer-associated bacteria (CAB) that impair tumor suppressor functions. Our previous research found that Mycoplasma fermentans DnaK, a chaperone protein, impairs p53 activities, which are essent...

Descrición completa

Gardado en:
Principais autores: Francesca Benedetti, Emmanuel F. Mongodin, Jonathan H. Badger, Arshi Munawwar, Ashley Cellini, Weirong Yuan, Giovannino Silvestri, Carl N. Kraus, Simone Marini, Chozha V. Rathinam, Marco Salemi, Hervé Tettelin, Robert C. Gallo, Davide Zella
Formato: Artigo
Idioma:Inglês
Publicado: BMC 2024-03-01
Series:Journal of Translational Medicine
Assuntos:
DnaK
Mycoplasma
Fusobacterium
Cisplatin
5FU
TCGA
Acceso en liña:https://doi.org/10.1186/s12967-024-05078-x
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares